• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板数量减少患者的凝血因子VIII/vWf水平升高。

Increased factor VIII/vWf levels in patients with reduced platelet number.

作者信息

Casonato A, Fabris F, Boscaro M, Girolami A

出版信息

Blut. 1987 May;54(5):281-8. doi: 10.1007/BF00320876.

DOI:10.1007/BF00320876
PMID:3105627
Abstract

Factor VIII/von Willebrand factor (VIII/vWf) related properties were studied in twenty six patients with thrombocytopenia. Fifteen patients were affected by idiopathic thrombocytopenic purpura (ITP) and 11 patients by thrombocytopenia of a different nature or non-ITP (n-ITP). All patients showed an enhancement of platelet associated IgG (PAIgG). A significant increase of factor VIII ristocetin cofactor (VIII R: RCoF) and factor VIII related antigen (VIII R:Ag) was found in ITP patients while normal values were observed for factor VIII coagulant (VIII:C). All factor VIII/vWf components, on the contrary, were increased in n-ITP group with a prevalence of VIII R:RCoF as observed in ITP group even though with lower mean values. Multimeric analysis of VIII/vWf demonstrated a higher concentration of all multimeric components, with major representation of higher molecular weight multimers (HMWM) in patients of both groups. Two patients were studied before and after improvement in platelet count. A decrease of vWf related properties (VIII R:RCoF and VIII R:Ag) concomitant with the increase in platelet count was found. In n-ITP patients a statistical correlation between VIII R:RCoF and PAIgG was also observed while no correlation was found between other factor VIII/vWf components and PAIgG both in ITP and n-ITP patients.

摘要

对26例血小板减少症患者的凝血因子VIII/血管性血友病因子(VIII/vWf)相关特性进行了研究。15例患者患有特发性血小板减少性紫癜(ITP),11例患者患有其他性质的血小板减少症或非ITP(n - ITP)。所有患者血小板相关IgG(PAIgG)均升高。ITP患者中凝血因子VIII瑞斯托霉素辅因子(VIII R:RCoF)和凝血因子VIII相关抗原(VIII R:Ag)显著增加,而凝血因子VIII促凝活性(VIII:C)值正常。相反,n - ITP组中所有VIII/vWf成分均增加,VIII R:RCoF占优势,与ITP组情况相同,尽管平均值较低。对VIII/vWf进行多聚体分析显示,两组患者所有多聚体成分浓度均较高,高分子量多聚体(HMWM)占主要部分。对2例患者在血小板计数改善前后进行了研究。发现随着血小板计数增加,vWf相关特性(VIII R:RCoF和VIII R:Ag)降低。在n - ITP患者中,还观察到VIII R:RCoF与PAIgG之间存在统计学相关性,而在ITP和n - ITP患者中,其他VIII/vWf成分与PAIgG之间均未发现相关性。

相似文献

1
Increased factor VIII/vWf levels in patients with reduced platelet number.血小板数量减少患者的凝血因子VIII/vWf水平升高。
Blut. 1987 May;54(5):281-8. doi: 10.1007/BF00320876.
2
Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.1型和2型先天性血管性血友病患者血管性血友病因子参数对去氨加压素的反应:诊断和治疗意义
Semin Thromb Hemost. 2002 Apr;28(2):111-32. doi: 10.1055/s-2002-27814.
3
Conformational changes in von Willebrand's factor protein: effects on the binding of factor VIII-coagulant.
Am J Hematol. 1986 Jun;22(2):113-22. doi: 10.1002/ajh.2830220202.
4
Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.假性血管性血友病。一种血小板内在缺陷,其表现为未修饰的人凝血因子VIII/血管性血友病因子可引起血小板聚集,且其高分子量多聚体的吸附增强。
N Engl J Med. 1982 Feb 11;306(6):326-33. doi: 10.1056/NEJM198202113060603.
5
Platelet-associated immunoglobulin G in childhood idiopathic thrombocytopenic purpura.儿童特发性血小板减少性紫癜中的血小板相关免疫球蛋白G
J Pediatr. 1983 Mar;102(3):366-70. doi: 10.1016/s0022-3476(83)80650-7.
6
The evaluation of factor VIII antigen by means of a simple slide test.通过简单玻片试验评估因子 VIII 抗原。
Am J Clin Pathol. 1985 Jul;84(1):107-11. doi: 10.1093/ajcp/84.1.107.
7
Platelet-type von Willebrand disease platelet aggregating factor: a novel functional assay of von Willebrand factor.血小板型血管性血友病血小板聚集因子:血管性血友病因子的一种新型功能检测方法。
Thromb Res. 1987 Nov 15;48(4):475-85. doi: 10.1016/0049-3848(87)90404-x.
8
Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis.
Br J Haematol. 1986 May;63(1):75-83. doi: 10.1111/j.1365-2141.1986.tb07497.x.
9
Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome.异常VIII:溶血性尿毒症综合征患者血浆中血管性血友病因子模式
Blood. 1984 Sep;64(3):592-8.
10
Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.血浆胶原蛋白辅助因子与血管性血友病因子抗原及瑞斯托霉素辅因子相关,但与出血时间无关。
Thromb Haemost. 1988 Jun 16;59(3):485-90.

引用本文的文献

1
Molecular Pathogenesis of Endotheliopathy and Endotheliopathic Syndromes, Leading to Inflammation and Microthrombosis, and Various Hemostatic Clinical Phenotypes Based on "Two-Activation Theory of the Endothelium" and "Two-Path Unifying Theory" of Hemostasis.内皮病和内皮病综合征的分子发病机制,导致炎症和微血栓形成,以及基于“内皮双重激活理论”和止血的“双途径统一理论”的各种止血临床表型。
Medicina (Kaunas). 2022 Sep 19;58(9):1311. doi: 10.3390/medicina58091311.
2
Pathogenesis of Two Faces of DVT: New Identity of Venous Thromboembolism as Combined Micro-Macrothrombosis via Unifying Mechanism Based on "Two-Path Unifying Theory" of Hemostasis and "Two-Activation Theory of the Endothelium".深静脉血栓形成两面性的发病机制:基于止血“双途径统一理论”和内皮“双激活理论”,通过统一机制将静脉血栓栓塞重新定义为微血栓与大血栓的组合
Life (Basel). 2022 Jan 31;12(2):220. doi: 10.3390/life12020220.
3

本文引用的文献

1
The possible value of platelet aggregation studies in patients with increased platelet number.血小板数量增多患者血小板聚集研究的潜在价值。
Blut. 1981 Nov;43(5):279-85. doi: 10.1007/BF00320951.
2
Platelets in myeloproliferative disorders. III: Glycoprotein profile in relation to platelet function and platelet density.骨髓增殖性疾病中的血小板。III:与血小板功能和血小板密度相关的糖蛋白谱
Scand J Haematol. 1981 Feb;26(2):123-9. doi: 10.1111/j.1600-0609.1981.tb01634.x.
3
A new method for the simultaneous quantitation of platelet-bound immunoglobuin (IgG) and complement (C3) employing an enzyme-linked immunosorbent assay (ELISA) procedure.
A characteristic flow cytometric pattern with broad forward scatter and narrowed side scatter helps diagnose immune thrombocytopenia (ITP).具有宽前向散射和窄侧向散射特征的流式细胞术模式有助于诊断免疫性血小板减少症 (ITP)。
Int J Hematol. 2018 Aug;108(2):151-160. doi: 10.1007/s12185-018-2454-y. Epub 2018 Apr 16.
Br J Haematol. 1980 Feb;44(2):281-90. doi: 10.1111/j.1365-2141.1980.tb01210.x.
4
Multimeric structure of platelet factor VIII/von Willebrand factor: the presence of larger multimers and their reassociation with thrombin-stimulated platelets.血小板因子VIII/血管性血友病因子的多聚体结构:更大的多聚体的存在及其与凝血酶刺激的血小板的重新结合。
Blood. 1982 Nov;60(5):1132-8.
5
Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state.
Thromb Haemost. 1982 Apr 30;47(2):116-7.
6
Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.假性血管性血友病。一种血小板内在缺陷,其表现为未修饰的人凝血因子VIII/血管性血友病因子可引起血小板聚集,且其高分子量多聚体的吸附增强。
N Engl J Med. 1982 Feb 11;306(6):326-33. doi: 10.1056/NEJM198202113060603.
7
Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration.在血浆浓度升高相关临床情况下,凝血因子VIII血管性血友病因子的改变。
Br J Haematol. 1981 Sep;49(1):61-8. doi: 10.1111/j.1365-2141.1981.tb07197.x.
8
Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.人去唾液酸因子VIII的特性。一种不依赖瑞斯托霉素的血小板聚集剂。
J Clin Invest. 1981 Aug;68(2):321-8. doi: 10.1172/jci110259.
9
Effect of multimeric structure of the factor VIII/von Willebrand factor protein on binding to platelets.凝血因子VIII/血管性血友病因子蛋白的多聚体结构对其与血小板结合的影响。
Blood. 1981 Aug;58(2):387-97.
10
The complex multimeric composition of factor VIII/von Willebrand factor.因子VIII/血管性血友病因子的复杂多聚体组成。
Blood. 1981 Jun;57(6):1140-3.